Suchergebnisse - "Venter, Willem"

PubPharm (13)

1

Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa

enthalten in: British journal of clinical pharmacology | 2024

von Mpofu, R. | Kawuma, A. | Wasmann, R. | +11

2

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans

enthalten in: Pharmacogenetics and genomics | 2023

von Mateza, S. | Bradford, Y. | Maartens, G. | +7

3

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population

enthalten in: CPT: pharmacometrics & systems pharmacology | 2023

von Kawuma, A. | Wasmann, R. | Sinxadi, P. | +6

4

Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV

enthalten in: Pharmacogenetics and genomics | 2023

von Cindi, Z. | Kawuma, A. | Maartens, G. | +10

5

Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Bosch, B. | Akpomiemie, G. | Chandiwana, N. | +6

6

Point-of-Care Tenofovir Urine Testing for the Prediction of Treatment Failure and Drug Resistance During Initial Treatment for Human Immunodeficiency Virus Type 1 (HIV-1) Infection

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Hermans, L. | Umunnakwe, C. | Lalla-Edward, S. | +5

7

The predicted risk of adverse pregnancy outcomes as a result of treatment-associated obesity in a hypothetical population receiving tenofovir alafenamide/emtricitabine/dolutegravir, tenofovir disoproxil fumarate/emtricitabine/dolutegravir or tenofovir disoproxil fumarate/emtricitabine/efavirenz

enthalten in: AIDS (London, England) | 2021

von Asif, S. | Baxevanidi, E. | Hill, A. | +6

8

Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir-Containing and Tenofovir-Containing Regimens

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2021

von Cindi, Z. | Maartens, G. | Bradford, Y. | +5

9

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE) : week 96 results from a randomised, phase 3, non-inferiority trial

enthalten in: The lancet. HIV | 2020

von Venter, W. | Sokhela, S. | Simmons, B. | +18

10

Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks : A Multicountry Randomized, Noninferiority Trial

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2019

von Venter, W. | Kambugu, A. | Chersich, M. | +13